Cell and Gene Therapy Manufacturing QC Market - Global Outlook and Forecast 2021-2027

March 2021 | 105 pages | ID: C8F45EAF0937EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cell and Gene Therapy Manufacturing QC in Global, including the following market information:

Global Cell and Gene Therapy Manufacturing QC Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cell and Gene Therapy Manufacturing QC market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell and Gene Therapy Manufacturing QC companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell and Gene Therapy Manufacturing QC Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cell and Gene Therapy Manufacturing QC Market Segment Percentages, By Type, 2020 (%)

• Safety Testing
• Purity Testing
• Potency Testing
• Identity Testing
• Stability Testing

China Cell and Gene Therapy Manufacturing QC Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cell and Gene Therapy Manufacturing QC Market Segment Percentages, By Application, 2020 (%)

• Precision Therapy
• Biological Research

Global Cell and Gene Therapy Manufacturing QC Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cell and Gene Therapy Manufacturing QC Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cell and Gene Therapy Manufacturing QC Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cell and Gene Therapy Manufacturing QC Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Bio-Techne Corporation
• BioMerieux SA
• Catalent, Inc.
• Charles River Laboratories International Inc.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd
• Intertek Group plc
• Lonza Group AG
• Merck KGaA
• Sartorius AG
• SGS S.A.
• Sistemic Scotland Limited
• Thermo Fisher Scientific Inc.
• Vigene Biosciences, Inc.
• WuXi AppTec

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cell and Gene Therapy Manufacturing QC Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Manufacturing QC Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELL AND GENE THERAPY MANUFACTURING QC OVERALL MARKET SIZE

2.1 Global Cell and Gene Therapy Manufacturing QC Market Size: 2021 VS 2027
2.2 Global Cell and Gene Therapy Manufacturing QC Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cell and Gene Therapy Manufacturing QC Players in Global Market
3.2 Top Global Cell and Gene Therapy Manufacturing QC Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Manufacturing QC Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing QC Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cell and Gene Therapy Manufacturing QC Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Players in Global Market
  3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing QC Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cell and Gene Therapy Manufacturing QC Market Size Markets, 2021 & 2027
  4.1.2 Safety Testing
  4.1.3 Purity Testing
  4.1.4 Potency Testing
  4.1.5 Identity Testing
  4.1.6 Stability Testing
4.2 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
  4.2.1 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, 2016-2021
  4.2.2 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, 2022-2027
  4.2.3 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cell and Gene Therapy Manufacturing QC Market Size, 2021 & 2027
  5.1.2 Precision Therapy
  5.1.3 Biological Research
5.2 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
  5.2.1 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, 2016-2021
  5.2.2 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, 2022-2027
  5.2.3 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cell and Gene Therapy Manufacturing QC Market Size, 2021 & 2027
6.2 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
  6.2.1 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue, 2016-2021
  6.2.2 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue, 2022-2027
  6.2.3 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, 2016-2027
  6.3.2 US Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.3.3 Canada Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.3.4 Mexico Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, 2016-2027
  6.4.2 Germany Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.4.3 France Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.4.4 U.K. Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.4.5 Italy Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.4.6 Russia Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.4.8 Benelux Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, 2016-2027
  6.5.2 China Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.5.3 Japan Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.5.4 South Korea Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.5.6 India Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, 2016-2027
  6.6.2 Brazil Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.6.3 Argentina Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, 2016-2027
  6.7.2 Turkey Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.7.3 Israel Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027
  6.7.5 UAE Cell and Gene Therapy Manufacturing QC Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Bio-Techne Corporation
  7.1.1 Bio-Techne Corporation Corporate Summary
  7.1.2 Bio-Techne Corporation Business Overview
  7.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.1.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.1.5 Bio-Techne Corporation Key News
7.2 BioMerieux SA
  7.2.1 BioMerieux SA Corporate Summary
  7.2.2 BioMerieux SA Business Overview
  7.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.2.4 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.2.5 BioMerieux SA Key News
7.3 Catalent, Inc.
  7.3.1 Catalent, Inc. Corporate Summary
  7.3.2 Catalent, Inc. Business Overview
  7.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.3.4 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.3.5 Catalent, Inc. Key News
7.4 Charles River Laboratories International Inc.
  7.4.1 Charles River Laboratories International Inc. Corporate Summary
  7.4.2 Charles River Laboratories International Inc. Business Overview
  7.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.4.4 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.4.5 Charles River Laboratories International Inc. Key News
7.5 Eurofins Scientific SE
  7.5.1 Eurofins Scientific SE Corporate Summary
  7.5.2 Eurofins Scientific SE Business Overview
  7.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.5.4 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.5.5 Eurofins Scientific SE Key News
7.6 F. Hoffmann-La Roche Ltd
  7.6.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.6.2 F. Hoffmann-La Roche Ltd Business Overview
  7.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.6.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.6.5 F. Hoffmann-La Roche Ltd Key News
7.7 Intertek Group plc
  7.7.1 Intertek Group plc Corporate Summary
  7.7.2 Intertek Group plc Business Overview
  7.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.4.4 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.7.5 Intertek Group plc Key News
7.8 Lonza Group AG
  7.8.1 Lonza Group AG Corporate Summary
  7.8.2 Lonza Group AG Business Overview
  7.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.8.4 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.8.5 Lonza Group AG Key News
7.9 Merck KGaA
  7.9.1 Merck KGaA Corporate Summary
  7.9.2 Merck KGaA Business Overview
  7.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.9.4 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.9.5 Merck KGaA Key News
7.10 Sartorius AG
  7.10.1 Sartorius AG Corporate Summary
  7.10.2 Sartorius AG Business Overview
  7.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.10.4 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.10.5 Sartorius AG Key News
7.11 SGS S.A.
  7.11.1 SGS S.A. Corporate Summary
  7.11.2 SGS S.A. Business Overview
  7.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.11.4 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.11.5 SGS S.A. Key News
7.12 Sistemic Scotland Limited
  7.12.1 Sistemic Scotland Limited Corporate Summary
  7.12.2 Sistemic Scotland Limited Business Overview
  7.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.12.4 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.12.5 Sistemic Scotland Limited Key News
7.13 Thermo Fisher Scientific Inc.
  7.13.1 Thermo Fisher Scientific Inc. Corporate Summary
  7.13.2 Thermo Fisher Scientific Inc. Business Overview
  7.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.13.4 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.13.5 Thermo Fisher Scientific Inc. Key News
7.14 Vigene Biosciences, Inc.
  7.14.1 Vigene Biosciences, Inc. Corporate Summary
  7.14.2 Vigene Biosciences, Inc. Business Overview
  7.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.14.4 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.14.5 Vigene Biosciences, Inc. Key News
7.15 WuXi AppTec
  7.15.1 WuXi AppTec Corporate Summary
  7.15.2 WuXi AppTec Business Overview
  7.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Major Product Offerings
  7.15.4 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue in Global (2016-2021)
  7.15.5 WuXi AppTec Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cell and Gene Therapy Manufacturing QC Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Manufacturing QC Market Drivers in Global Market
Table 3. Cell and Gene Therapy Manufacturing QC Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy Manufacturing QC in Global Market
Table 5. Top Cell and Gene Therapy Manufacturing QC Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cell and Gene Therapy Manufacturing QC Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cell and Gene Therapy Manufacturing QC Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Manufacturing QC Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022-2027
Table 30. Bio-Techne Corporation Corporate Summary
Table 31. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product Offerings
Table 32. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 33. BioMerieux SA Corporate Summary
Table 34. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product Offerings
Table 35. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 36. Catalent, Inc. Corporate Summary
Table 37. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 38. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 39. Charles River Laboratories International Inc. Corporate Summary
Table 40. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 41. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 42. Eurofins Scientific SE Corporate Summary
Table 43. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product Offerings
Table 44. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 45. F. Hoffmann-La Roche Ltd Corporate Summary
Table 46. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product Offerings
Table 47. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 48. Intertek Group plc Corporate Summary
Table 49. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product Offerings
Table 50. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 51. Lonza Group AG Corporate Summary
Table 52. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product Offerings
Table 53. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 54. Merck KGaA Corporate Summary
Table 55. Merck KGaA Cell and Gene Therapy Manufacturing QC Product Offerings
Table 56. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 57. Sartorius AG Corporate Summary
Table 58. Sartorius AG Cell and Gene Therapy Manufacturing QC Product Offerings
Table 59. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 60. SGS S.A. Corporate Summary
Table 61. SGS S.A. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 62. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 63. Sistemic Scotland Limited Corporate Summary
Table 64. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product Offerings
Table 65. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 66. Thermo Fisher Scientific Inc. Corporate Summary
Table 67. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 68. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 69. Vigene Biosciences, Inc. Corporate Summary
Table 70. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 71. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)
Table 72. WuXi AppTec Corporate Summary
Table 73. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product Offerings
Table 74. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Cell and Gene Therapy Manufacturing QC Segment by Type
Figure 2. Cell and Gene Therapy Manufacturing QC Segment by Application
Figure 3. Global Cell and Gene Therapy Manufacturing QC Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Manufacturing QC Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Manufacturing QC Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2020
Figure 8. By Type - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 12. US Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 16. Germany Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 17. France Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 24. China Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 28. India Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 30. Brazil Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2016-2027
Figure 33. Turkey Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2016-2027
Figure 37. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2016-2021)